| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |